BIRC3 | Baculoviral IAP repeat containing 3 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BIRC5 | Baculoviral IAP repeat containing 5 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
BIRC6 | Baculoviral IAP repeat containing 6 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BLK | BLK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BMI1 | BMI1 proto-oncogene, polycomb ring finger | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BMP2 | Bone morphogenetic protein 2 | Cancer-related genes Predicted secreted proteins
| | | | | Mixed |
BMP4 | Bone morphogenetic protein 4 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
BMPR1A | Bone morphogenetic protein receptor, type IA | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BRAF | B-Raf proto-oncogene, serine/threonine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BRCA1 | Breast cancer 1, early onset | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BRD3 | Bromodomain containing 3 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRD4 | Bromodomain containing 4 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRE | Brain and reproductive organ-expressed (TNFRSF1A modulator) | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BRMS1 | Breast cancer metastasis suppressor 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BTG1 | B-cell translocation gene 1, anti-proliferative | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
BTG2 | BTG family, member 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf65 | Chromosome 15 open reading frame 65 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
C18orf8 | Chromosome 18 open reading frame 8 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
C1QBP | Complement component 1, q subcomponent binding protein | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
C2orf44 | Chromosome 2 open reading frame 44 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
C3orf70 | Chromosome 3 open reading frame 70 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Group enriched |
C7 | Complement component 7 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA8 | Carbonic anhydrase VIII | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CACNA1D | Calcium channel, voltage-dependent, L type, alpha 1D subunit | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CALCA | Calcitonin-related polypeptide alpha | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CALM1 | Calmodulin 1 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM2 | Calmodulin 2 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALM3 | Calmodulin 3 (phosphorylase kinase, delta) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
CALR | Calreticulin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CAMTA1 | Calmodulin binding transcription activator 1 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
CANT1 | Calcium activated nucleotidase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPN6 | Calpain 6 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CARD11 | Caspase recruitment domain family, member 11 | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASC3 | Cancer susceptibility candidate 3 | Cancer-related genes Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASP1 | Caspase 1, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CASP10 | Caspase 10, apoptosis-related cysteine peptidase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |